Citations (18)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (2)
Linna Ma, Yurong Cao, Yue Ma & Jun Zhai. (2021) Association between hyperandrogenism and adverse pregnancy outcomes in patients with different polycystic ovary syndrome phenotypes undergoing in vitro fertilization/intracytoplasmic sperm injection: a systematic review and meta-analysis. Gynecological Endocrinology 37:8, pages 694-701.
Read now
Read now
Meryem Hocaoglu, Selin Demirer, Ilayda Loclar Karaalp, Esra Kaynak, Erkut Attar, Abdulkadir Turgut, Ates Karateke & Evrim Komurcu-Bayrak. (2021) Identification of miR-16-5p and miR-155-5p microRNAs differentially expressed in circulating leukocytes of pregnant women with polycystic ovary syndrome and gestational diabetes. Gynecological Endocrinology 37:3, pages 216-220.
Read now
Read now
Articles from other publishers (16)
Berat Eralp, Mujde Can Ibanoglu & Yaprak Engin‐Ustun. (2023) Evaluation of pregnancy and neonatal outcomes according to the phenotypic types of polycystic ovary syndrome: A prospective study. International Journal of Gynecology & Obstetrics 163:3, pages 894-903.
Crossref
Crossref
Qingzi Yan, Dan Qiu, Xiang Liu, Qichang Xing, Renzhu Liu & Yixiang Hu. (2022) The incidence of gestational diabetes mellitus among women with polycystic ovary syndrome: a meta-analysis of longitudinal studies. BMC Pregnancy and Childbirth 22:1.
Crossref
Crossref
Ashwini Joshi, Ashley Aluko, Aaron K. Styer, Brett C. Young, Katherine M. Johnson, Michele R. Hacker & Anna M. Modest. (2022) PCOS and the risk of pre-eclampsia. Reproductive BioMedicine Online 45:5, pages 961-969.
Crossref
Crossref
Leslie V Farland, Judy E Stern, Chia-Ling Liu, Howard J Cabral, Charles C CoddingtonIIIIII, Hafsatou Diop, Dmitry Dukhovny, Sunah Hwang & Stacey A Missmer. (2022) Polycystic ovary syndrome and risk of adverse pregnancy outcomes: a registry linkage study from Massachusetts. Human Reproduction 37:11, pages 2690-2699.
Crossref
Crossref
Femi Janse & Bart C. J. M. Fauser. 2022. Polycystic Ovary Syndrome. Polycystic Ovary Syndrome
131
141
.
Christos Chatzakis, Evangelia Tsakmaki, Aggeliki Psomiadou, Nikolaos Charitakis, Makarios Eleftheriades, Konstantinos Dinas, Dimitrios Goulis & Alexandros Sotiriadis. (2022) Different pregnancy outcomes according to the polycystic ovary syndrome diagnostic criteria: a systematic review and meta-analysis of 79 studies. Fertility and Sterility 117:4, pages 854-881.
Crossref
Crossref
Maurizio N. D’ALTERIO, Marco SIGILLI, Antonio G. SUCCU, Valeria GHISU, Antonio S. LAGANÀ, Felice SORRENTINO, Luigi NAPPI, Raffaele TINELLI & Stefano ANGIONI. (2022) Pregnancy outcomes in women with polycystic ovarian syndrome. Minerva Obstetrics and Gynecology 74:1.
Crossref
Crossref
Jingyuan Wang, Bohan Lv, Xiujuan Chen, Yueshuai Pan, Kai Chen, Yan Zhang, Qianqian Li, Lili Wei & Yan Liu. (2021) An early model to predict the risk of gestational diabetes mellitus in the absence of blood examination indexes: application in primary health care centres. BMC Pregnancy and Childbirth 21:1.
Crossref
Crossref
H Valgeirsdottir, T Kunovac Kallak, I Sundström Poromaa, M Jonsson, N Roos, L Lindström & A‐K Wikström. (2021) Polycystic ovary syndrome and risk of stillbirth: a nationwide register‐based study. BJOG: An International Journal of Obstetrics & Gynaecology 128:13, pages 2073-2082.
Crossref
Crossref
Haixia Pan, Peiyi Xian, Daopeng Yang, Chunren Zhang, Huizhen Tang, Xiaoying He, Han Lin, Xiaohui Wen, Hongxia Ma & Maohua Lai. (2021) Polycystic ovary syndrome is an independent risk factor for hypertensive disorders of pregnancy: A systematic review, meta-analysis, and meta-regression. Endocrine 74:3, pages 518-529.
Crossref
Crossref
Ting Yu, Di Wu, Yurong Cao & Jun Zhai. (2021) Association Between Menstrual Patterns and Adverse Pregnancy Outcomes in Patients With Polycystic Ovary Syndrome. Frontiers in Endocrinology 12.
Crossref
Crossref
Krystallenia I Alexandraki, Eleni A Kandaraki, Kalliopi-Anna Poulia, Christina Piperi, Eirini Papadimitriou & Theodoros G Papaioannou. (2021) Assessment of Early Markers of Cardiovascular Risk in Polycystic Ovary Syndrome. European Endocrinology 1:1, pages 37.
Crossref
Crossref
Xianqin Qu & Richard Donnelly. (2020) Sex Hormone-Binding Globulin (SHBG) as an Early Biomarker and Therapeutic Target in Polycystic Ovary Syndrome. International Journal of Molecular Sciences 21:21, pages 8191.
Crossref
Crossref
Ginevra Mills, Ahmad Badeghiesh, Eva Suarthana, Haitham Baghlaf & Michael H Dahan. (2020) Associations between polycystic ovary syndrome and adverse obstetric and neonatal outcomes: a population study of 9.1 million births. Human Reproduction 35:8, pages 1914-1921.
Crossref
Crossref
R. Vanda, Sh. Aramesh, M. Sadeghian, M.A. Ghatee & P. Ghaffari. (2020) Effect of Aspirin on Pre-eclampsia and Fetal Growth Restriction in Obese Pregnant Women: A Randomized Controlled Clinical Trial. Journal of Clinical Care and Skills 1:4, pages 159-164.
Crossref
Crossref
Ginevra Mills, Ahmad Badeghiesh, Eva Suarthana, Haitham Baghlaf & Michael H Dahan. (2020) Polycystic ovary syndrome as an independent risk factor for gestational diabetes and hypertensive disorders of pregnancy: a population-based study on 9.1 million pregnancies. Human Reproduction 35:7, pages 1666-1674.
Crossref
Crossref